KLK3 and prostate cancer: VEGF-C expression, which overlaps in the prostate with KLK3 expression (Joory et al., 2006), is similarly controversial, with some studies supporting (Jennbacken et al., 2005; Yang et al., 2014) and others refuting (Mori et al., 2010) its predictive ability for prostate cancer progression.